Article PDF
Avoid common mistakes on your manuscript.
Funding
The PARITY trial received funding through research grants from the Canadian Institutes of Health Research (CIHR), the Canadian Cancer Society Research Institute, the Canadian Orthopaedic Foundation, the Orthopaedic Research and Education Foundation in conjunction with the Musculoskeletal Tumor Society, and the Physicians’ Services Incorporated research grant. M.G. reports speaker fees from Stryker.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Disclosure
All other authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gazendam, A.M., Schneider, P., Spiguel, A. et al. ASO Visual Abstract: Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower-Extremity Sarcomas—Does Timing Impact Complication Rates?. Ann Surg Oncol 29, 7319 (2022). https://doi.org/10.1245/s10434-022-12374-7
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12374-7